Trevi Therapeutics
  • Our Science
    • Haduvio™
    • Publications
    • Partnering
  • Pipeline & Clinical Trials
    • Pipeline
    • Previous Clinical Trials
  • Investors & News
    • Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Stock Price
      • Analyst Coverage
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Governance
      • Documents & Charters
      • Board Committees
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • About Us
    • Leadership
    • Board of Directors
    • Commitment to Patients
    • Life at Trevi
    • Benefits
    • Careers
  • Contact
Trevi Therapeutics
  • Our Science
    • Haduvio™
    • Publications
    • Partnering
  • Pipeline & Clinical Trials
    • Pipeline
    • Previous Clinical Trials
  • Investors & News
    • Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Stock Price
      • Analyst Coverage
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
    • Governance
      • Documents & Charters
      • Board Committees
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • About Us
    • Leadership
    • Board of Directors
    • Commitment to Patients
    • Life at Trevi
    • Benefits
    • Careers
  • Contact

Contact

Trevi Therapeutics is located at:

195 Church Street, 16th Floor
New Haven, CT 06510

(203) 304-2499

General Information

info@trevitherapeutics.com

Business Development

bd@trevitherapeutics.com

Employment

hr@trevitherapeutics.com

Investor Relations

carlsonj@trevitherapeutics.com

Media Contact

rscampoli@marketcompr.com

Directions by Car

(to come)

Parking

(to come)

Directions by Train

(to come)

  • U.S. Website Privacy Notice
  • GDPR Data Protection Notice
  • Terms of Use
  • Twitter
  • Linkedin
Haduvio (nalbuphine ER) is an investigational therapy and not yet approved for use in any indication.
© 2025 Trevi Therapeutics, All Rights Reserved. Terms of Service. Website by D&CO